References
- United States Renal Data System. 1999 Annual Data Report. Am J Kidney Dis 1999; 35(Suppl 1): S1–132
- Reikes ST. Trends in end-stage renal disease: epidemiology, morbidity, and mortality. Postgrad Med 2000; 108(1): 124–42
- Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35(4 Suppl 1): S117–31
- Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32(5): 853–906
- Schmitz PG. Progressive renal insufficiency: office strategies to prevent or slow progression of kidney disease. Postgrad Med 2000; 108(1): 145–54
- Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58(1): 353–62
- Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47(1): 186–92
- Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27(3): 347–54
- Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 (5 Suppl): 180–93
- Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36(3): 646–61
- Pereira BJ. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 2000; 57(1): 351–65
- Keane WF. Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000; 35(4 Suppl 1): S97–105
- Keane WF, Eknoyan G. Proteinuria, albuminuria, risk assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 1999; 35(5): 1004–10
- Levey AS, Greene T, Schluchter MD, et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993; 4(5): 1159–71
- Eknoyan G, Levin NW. An overview of the National Kidney Foundation-Dialysis Outcomes Quality Initiative Implementation. Adv Ren Replace Ther 1999; 6(1): 3–6
- Eknoyan G, Levin NW, Steinberg EP. The dialysis outcomes quality initiative: history, impact, and prospects. Am J Kidney Dis 2000; 35(4 Suppl 1): S69–75